Estrella Immunopharma, Inc.
ESLA
$0.97
$0.00050.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.32M | 421.50K | 1.80M | 1.80M | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 163.90K | 522.80K | 437.60K | 437.60K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.48M | 944.30K | 2.24M | 2.24M | 4.45M |
|
|
|||||
| Total Current Assets | 1.48M | 944.30K | 2.24M | 2.24M | 4.45M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.50M | 1.50M | 1.50M | 1.50M | -- |
| Total Assets | 2.98M | 2.44M | 3.74M | 3.74M | 4.45M |
|
|
|||||
| Total Accounts Payable | 8.20K | 14.00K | 5.00K | 5.00K | -- |
| Total Accrued Expenses | 8.88M | 4.25M | 2.94M | 2.94M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.00K | 10.00K | 4.00K | 4.00K | -- |
| Total Finance Division Other Current Liabilities | 187.90K | 3.30K | 43.60K | 43.60K | -- |
| Total Other Current Liabilities | 187.90K | 3.30K | 43.60K | 43.60K | -- |
| Total Current Liabilities | 9.08M | 4.28M | 2.99M | 2.99M | 180.70K |
|
|
|||||
| Total Current Liabilities | 9.08M | 4.28M | 2.99M | 2.99M | 180.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.08M | 4.28M | 2.99M | 2.99M | 180.70K |
|
|
|||||
| Common Stock & APIC | 26.08M | 24.80M | 24.13M | 24.13M | -- |
| Retained Earnings | -31.58M | -26.03M | -22.88M | -22.88M | -19.50M |
| Treasury Stock & Other | -598.40K | -598.40K | -504.90K | -504.90K | -- |
| Total Common Equity | -6.09M | -1.83M | 746.30K | 746.30K | 4.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.09M | -1.83M | 746.30K | 746.30K | 4.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.09M | -1.83M | 746.30K | 746.30K | -- |
|
|
|||||